stars 1 stars 2 stars 3

EmbryoCloud is a novel concept in the world of Assisted Reproductive Technologies (ARTs) trying to come back to Nature and get a more healthy environment for the gametes and embryos in the IVF laboratories. This environment includes the design of novel culture media with natural components of the reproductive fluids in their composition, the design of novel protocols for gamete manipulation or the design of new devices for embryo transfers. This new concept is the result of decades of research in the field of Reproductive Biology embodied in the Patent No. ES 2532659 A1 “Processing and use of reproductive tract fluids to improve the in vitro production of mammalian embryos”. EmbryoCloud fully adheres to the phylosophy of One Health Initiative, linking human, animal and environmental health. For this reason, NaturARTs, the first line of products launched will soon include a division with fluids from sheep, goat and equine, as well as a human division with natural additives available for the human culture media.

EmbryoCloud Questions

The EmbryoCloud annual revenue was $2 million in 2026.

5 people are employed at EmbryoCloud.

The NAICS codes for EmbryoCloud are [3254, 32, 325, 32541, 325414].

The SIC codes for EmbryoCloud are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users